|
PIK3C3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.96196400739746E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.54779997099774E-09 |
| Normal-vs-Stage2 |
2.50460000517094E-08 |
| Normal-vs-Stage3 |
2.22000196004046E-11 |
| Normal-vs-Stage4 |
1.8478996111071E-11 |
| Stage1-vs-Stage2 |
1.532390E-01 |
| Stage1-vs-Stage3 |
9.060400E-02 |
| Stage1-vs-Stage4 |
8.999300E-03 |
| Stage2-vs-Stage3 |
8.417800E-01 |
| Stage2-vs-Stage4 |
5.762800E-01 |
| Stage3-vs-Stage4 |
3.696200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.3665957254716E-11 |
| Normal-vs-AfricanAmerican |
1.192500E-04 |
| Normal-vs-Asian |
7.01699999994254E-07 |
| Caucasian-vs-AfricanAmerican |
7.332600E-01 |
| Caucasian-vs-Asian |
9.655000E-01 |
| AfricanAmerican-vs-Asian |
7.914000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.44213587924969E-13 |
| Normal-vs-Female |
7.28289650808733E-11 |
| Male-vs-Female |
6.333700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.68170000334345E-08 |
| Normal-vs-Age(41-60Yrs) |
2.22519780379571E-11 |
| Normal-vs-Age(61-80Yrs) |
2.43016717860201E-12 |
| Normal-vs-Age(81-100Yrs) |
7.432900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.029560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.092300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.835600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.170800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.018800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.412200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.457560E-01 |
| Classical-VS-Follicular |
9.95639999999964E-05 |
| Classical-VS-Other |
2.505000E-01 |
| Classical-VS-Normal |
1.53769996735775E-09 |
| Tall-VS-Follicular |
3.301000E-01 |
| Tall-VS-Other |
6.832400E-01 |
| Tall-VS-Normal |
3.36479999973882E-07 |
| Follicular-VS-Other |
8.673800E-01 |
| Follicular-VS-Normal |
1.08389963671129E-11 |
| Other-VS-Normal |
1.563620E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.92859095149834E-13 |
| Normal-vs-N1 |
1.64599999963322E-07 |
| N0-vs-N1 |
9.542000E-01 |
|
|
